1. IR @ Alliance University
  2. Journal Articles Archive
  3. Articles to be qced
Please use this identifier to cite or link to this item: https://gnanaganga.inflibnet.ac.in:8443/jspui/handle/123456789/10672
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBinita Angom-
dc.contributor.authorPrabhakar Maurya-
dc.date.accessioned2024-02-27T07:52:29Z-
dc.date.available2024-02-27T07:52:29Z-
dc.date.issued2016-
dc.identifier.urihttp://gnanaganga.inflibnet.ac.in:8080/jspui/handle/123456789/10672-
dc.description.abstractPharmaceutical indusliy, a promising sector constantly generating new intellectual property is third largest in terms of volume and thirteenth largest in terms of value. India is one of the largest providers of generic ugs contributing almost 20% of the worlds share. Due to flagship programmes such as Make in India substantial effect is reflected on innovation scenario as India has jumped the ranking this year in Global Innovation Index compiled by WIPO.-
dc.publisherGGGI Bi-Annual Refereed International Journal of Management-
dc.titlePublic Health Implications of IPR Policies in Pharmaceutical Industry with Special Reference to India-
dc.volVol 6-
dc.issuedNo 2-
Appears in Collections:Articles to be qced

Files in This Item:
File SizeFormat 
PUBLIC HEAL TH IMPLICATIONS OF IPR POLICIES IN PHARMACEUTICAL INDUSTRY WITH SPECIAL REFERENCE TO INDIA.pdf
  Restricted Access		4.47 MBAdobe PDFView/Open Request a copy
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.